Replies to post #34318 on Savvy Trades and Investments

[micham2012]

CNAT:

Still holding 70% of shares. Sold 30% at $7.65.

Roth Capital has increased price target from $4 to $12:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=130702786

And, encouraging data reported last week:

http://ih.advfn.com/p.php?pid=nmona&article=74387481

If CNAT crosses $10, does it become eligible for biotech fund buying?